Blood Plasma Fractionation Industry Research Report 2023
Highlights
The global Blood Plasma Fractionation market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North American market for Blood Plasma Fractionation is estimated to increase from $ million in 2022 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Blood Plasma Fractionation is estimated to increase from $ million in 2022 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The major global manufacturers of Blood Plasma Fractionation include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and RAAS, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
The global market for Blood Plasma Fractionation in Hospital is estimated to increase from $ million in 2022 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Immune Globulin, which accounted for % of the global market of Blood Plasma Fractionation in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2023 to 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Blood Plasma Fractionation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Plasma Fractionation.
The Blood Plasma Fractionation market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Blood Plasma Fractionation market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Plasma Fractionation manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Blood Plasma Fractionation type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Blood Plasma Fractionation are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Blood Plasma Fractionation segment by Type
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Blood Plasma Fractionation market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Blood Plasma Fractionation market.
Blood Plasma Fractionation segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Blood Plasma Fractionation market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Plasma Fractionation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Blood Plasma Fractionation and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Blood Plasma Fractionation industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Plasma Fractionation.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Blood Plasma Fractionation manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Blood Plasma Fractionation by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Blood Plasma Fractionation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
The global Blood Plasma Fractionation market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North American market for Blood Plasma Fractionation is estimated to increase from $ million in 2022 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Blood Plasma Fractionation is estimated to increase from $ million in 2022 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The major global manufacturers of Blood Plasma Fractionation include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and RAAS, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
The global market for Blood Plasma Fractionation in Hospital is estimated to increase from $ million in 2022 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Immune Globulin, which accounted for % of the global market of Blood Plasma Fractionation in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2023 to 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Blood Plasma Fractionation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Plasma Fractionation.
The Blood Plasma Fractionation market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Blood Plasma Fractionation market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Plasma Fractionation manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Takeda
- CSL
- Grifols
- Octapharma
- Kedrion
- LFB Group
- Biotest
- BPL
- RAAS
- CBPO
- Hualan Bio
- Tiantan Bio
- Shuanglin Bio
- Boya Bio
- Yuanda Shuyang
- Weiguang Bio
- Nanyue Bio
- KM Biologics
Global markets are presented by Blood Plasma Fractionation type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Blood Plasma Fractionation are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Blood Plasma Fractionation segment by Type
- Immune Globulin
- Coagulation Factor
- Albumin
- Others
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Blood Plasma Fractionation market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Blood Plasma Fractionation market.
Blood Plasma Fractionation segment by Application
- Hospital
- Retail Pharmacy
- Others
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Blood Plasma Fractionation market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Plasma Fractionation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Blood Plasma Fractionation and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Blood Plasma Fractionation industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Plasma Fractionation.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Blood Plasma Fractionation manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Blood Plasma Fractionation by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Blood Plasma Fractionation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Blood Plasma Fractionation Market Size (2018-2029) & (US$ Million)
2.2.2 Global Blood Plasma Fractionation Sales (2018-2029)
2.2.3 Global Blood Plasma Fractionation Market Average Price (2018-2029)
2.3 Blood Plasma Fractionation by Type
2.3.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Immune Globulin
1.2.3 Coagulation Factor
1.2.4 Albumin
1.2.5 Others
2.4 Blood Plasma Fractionation by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Hospital
2.4.3 Retail Pharmacy
2.4.4 Others
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Blood Plasma Fractionation Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global Blood Plasma Fractionation Sales (K Units) of Manufacturers (2018-2023)
3.3 Global Blood Plasma Fractionation Revenue of Manufacturers (2018-2023)
3.4 Global Blood Plasma Fractionation Average Price by Manufacturers (2018-2023)
3.5 Global Blood Plasma Fractionation Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of Blood Plasma Fractionation, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Blood Plasma Fractionation, Product Type & Application
3.8 Global Manufacturers of Blood Plasma Fractionation, Date of Enter into This Industry
3.9 Global Blood Plasma Fractionation Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Takeda
4.1.1 Takeda Company Information
4.1.2 Takeda Business Overview
4.1.3 Takeda Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
4.1.4 Takeda Blood Plasma Fractionation Product Portfolio
4.1.5 Takeda Recent Developments
4.2 CSL
4.2.1 CSL Company Information
4.2.2 CSL Business Overview
4.2.3 CSL Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
4.2.4 CSL Blood Plasma Fractionation Product Portfolio
4.2.5 CSL Recent Developments
4.3 Grifols
4.3.1 Grifols Company Information
4.3.2 Grifols Business Overview
4.3.3 Grifols Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
4.3.4 Grifols Blood Plasma Fractionation Product Portfolio
4.3.5 Grifols Recent Developments
4.4 Octapharma
4.4.1 Octapharma Company Information
4.4.2 Octapharma Business Overview
4.4.3 Octapharma Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
4.4.4 Octapharma Blood Plasma Fractionation Product Portfolio
4.4.5 Octapharma Recent Developments
4.5 Kedrion
4.5.1 Kedrion Company Information
4.5.2 Kedrion Business Overview
4.5.3 Kedrion Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Kedrion Blood Plasma Fractionation Product Portfolio
6.5.5 Kedrion Recent Developments
4.6 LFB Group
4.6.1 LFB Group Company Information
4.6.2 LFB Group Business Overview
4.6.3 LFB Group Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
4.6.4 LFB Group Blood Plasma Fractionation Product Portfolio
4.6.5 LFB Group Recent Developments
4.7 Biotest
4.7.1 Biotest Company Information
4.7.2 Biotest Business Overview
4.7.3 Biotest Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
4.7.4 Biotest Blood Plasma Fractionation Product Portfolio
4.7.5 Biotest Recent Developments
6.8 BPL
4.8.1 BPL Company Information
4.8.2 BPL Business Overview
4.8.3 BPL Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
4.8.4 BPL Blood Plasma Fractionation Product Portfolio
4.8.5 BPL Recent Developments
4.9 RAAS
4.9.1 RAAS Company Information
4.9.2 RAAS Business Overview
4.9.3 RAAS Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
4.9.4 RAAS Blood Plasma Fractionation Product Portfolio
4.9.5 RAAS Recent Developments
4.10 CBPO
4.10.1 CBPO Company Information
4.10.2 CBPO Business Overview
4.10.3 CBPO Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
4.10.4 CBPO Blood Plasma Fractionation Product Portfolio
4.10.5 CBPO Recent Developments
6.11 Hualan Bio
6.11.1 Hualan Bio Company Information
6.11.2 Hualan Bio Blood Plasma Fractionation Business Overview
6.11.3 Hualan Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Hualan Bio Blood Plasma Fractionation Product Portfolio
6.11.5 Hualan Bio Recent Developments
6.12 Tiantan Bio
6.12.1 Tiantan Bio Company Information
6.12.2 Tiantan Bio Blood Plasma Fractionation Business Overview
6.12.3 Tiantan Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Tiantan Bio Blood Plasma Fractionation Product Portfolio
6.12.5 Tiantan Bio Recent Developments
6.13 Shuanglin Bio
6.13.1 Shuanglin Bio Company Information
6.13.2 Shuanglin Bio Blood Plasma Fractionation Business Overview
6.13.3 Shuanglin Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Shuanglin Bio Blood Plasma Fractionation Product Portfolio
6.13.5 Shuanglin Bio Recent Developments
6.14 Boya Bio
6.14.1 Boya Bio Company Information
6.14.2 Boya Bio Blood Plasma Fractionation Business Overview
6.14.3 Boya Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Boya Bio Blood Plasma Fractionation Product Portfolio
6.14.5 Boya Bio Recent Developments
6.15 Yuanda Shuyang
6.15.1 Yuanda Shuyang Company Information
6.15.2 Yuanda Shuyang Blood Plasma Fractionation Business Overview
6.15.3 Yuanda Shuyang Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Yuanda Shuyang Blood Plasma Fractionation Product Portfolio
6.15.5 Yuanda Shuyang Recent Developments
6.16 Weiguang Bio
6.16.1 Weiguang Bio Company Information
6.16.2 Weiguang Bio Blood Plasma Fractionation Business Overview
6.16.3 Weiguang Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Weiguang Bio Blood Plasma Fractionation Product Portfolio
6.16.5 Weiguang Bio Recent Developments
6.17 Nanyue Bio
6.17.1 Nanyue Bio Company Information
6.17.2 Nanyue Bio Blood Plasma Fractionation Business Overview
6.17.3 Nanyue Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Nanyue Bio Blood Plasma Fractionation Product Portfolio
6.17.5 Nanyue Bio Recent Developments
6.18 KM Biologics
6.18.1 KM Biologics Company Information
6.18.2 KM Biologics Blood Plasma Fractionation Business Overview
6.18.3 KM Biologics Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.18.4 KM Biologics Blood Plasma Fractionation Product Portfolio
6.18.5 KM Biologics Recent Developments
5 GLOBAL BLOOD PLASMA FRACTIONATION MARKET SCENARIO BY REGION
5.1 Global Blood Plasma Fractionation Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Blood Plasma Fractionation Sales by Region: 2018-2029
5.2.1 Global Blood Plasma Fractionation Sales by Region: 2018-2023
5.2.2 Global Blood Plasma Fractionation Sales by Region: 2024-2029
5.3 Global Blood Plasma Fractionation Revenue by Region: 2018-2029
5.3.1 Global Blood Plasma Fractionation Revenue by Region: 2018-2023
5.3.2 Global Blood Plasma Fractionation Revenue by Region: 2024-2029
5.4 North America Blood Plasma Fractionation Market Facts & Figures by Country
5.4.1 North America Blood Plasma Fractionation Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America Blood Plasma Fractionation Sales by Country (2018-2029)
5.4.3 North America Blood Plasma Fractionation Revenue by Country (2018-2029)
5.4.4 United States
5.4.5 Canada
5.5 Europe Blood Plasma Fractionation Market Facts & Figures by Country
5.5.1 Europe Blood Plasma Fractionation Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe Blood Plasma Fractionation Sales by Country (2018-2029)
5.5.3 Europe Blood Plasma Fractionation Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Blood Plasma Fractionation Market Facts & Figures by Country
5.6.1 Asia Pacific Blood Plasma Fractionation Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific Blood Plasma Fractionation Sales by Country (2018-2029)
5.6.3 Asia Pacific Blood Plasma Fractionation Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Blood Plasma Fractionation Market Facts & Figures by Country
5.7.1 Latin America Blood Plasma Fractionation Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America Blood Plasma Fractionation Sales by Country (2018-2029)
5.7.3 Latin America Blood Plasma Fractionation Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Blood Plasma Fractionation Market Facts & Figures by Country
5.8.1 Middle East and Africa Blood Plasma Fractionation Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa Blood Plasma Fractionation Sales by Country (2018-2029)
5.8.3 Middle East and Africa Blood Plasma Fractionation Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Blood Plasma Fractionation Sales by Type (2018-2029)
6.1.1 Global Blood Plasma Fractionation Sales by Type (2018-2029) & (K Units)
6.1.2 Global Blood Plasma Fractionation Sales Market Share by Type (2018-2029)
6.2 Global Blood Plasma Fractionation Revenue by Type (2018-2029)
6.2.1 Global Blood Plasma Fractionation Sales by Type (2018-2029) & (US$ Million)
6.2.2 Global Blood Plasma Fractionation Revenue Market Share by Type (2018-2029)
6.3 Global Blood Plasma Fractionation Price by Type (2018-2029)
7 SEGMENT BY APPLICATION
7.1 Global Blood Plasma Fractionation Sales by Application (2018-2029)
7.1.1 Global Blood Plasma Fractionation Sales by Application (2018-2029) & (K Units)
7.1.2 Global Blood Plasma Fractionation Sales Market Share by Application (2018-2029)
7.2 Global Blood Plasma Fractionation Revenue by Application (2018-2029)
6.2.1 Global Blood Plasma Fractionation Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global Blood Plasma Fractionation Revenue Market Share by Application (2018-2029)
7.3 Global Blood Plasma Fractionation Price by Application (2018-2029)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Blood Plasma Fractionation Value Chain Analysis
8.1.1 Blood Plasma Fractionation Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Blood Plasma Fractionation Production Mode & Process
8.2 Blood Plasma Fractionation Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Blood Plasma Fractionation Distributors
8.2.3 Blood Plasma Fractionation Customers
9 GLOBAL BLOOD PLASMA FRACTIONATION ANALYZING MARKET DYNAMICS
9.1 Blood Plasma Fractionation Industry Trends
9.2 Blood Plasma Fractionation Industry Drivers
9.3 Blood Plasma Fractionation Industry Opportunities and Challenges
9.4 Blood Plasma Fractionation Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Blood Plasma Fractionation Market Size (2018-2029) & (US$ Million)
2.2.2 Global Blood Plasma Fractionation Sales (2018-2029)
2.2.3 Global Blood Plasma Fractionation Market Average Price (2018-2029)
2.3 Blood Plasma Fractionation by Type
2.3.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Immune Globulin
1.2.3 Coagulation Factor
1.2.4 Albumin
1.2.5 Others
2.4 Blood Plasma Fractionation by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Hospital
2.4.3 Retail Pharmacy
2.4.4 Others
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Blood Plasma Fractionation Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global Blood Plasma Fractionation Sales (K Units) of Manufacturers (2018-2023)
3.3 Global Blood Plasma Fractionation Revenue of Manufacturers (2018-2023)
3.4 Global Blood Plasma Fractionation Average Price by Manufacturers (2018-2023)
3.5 Global Blood Plasma Fractionation Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of Blood Plasma Fractionation, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Blood Plasma Fractionation, Product Type & Application
3.8 Global Manufacturers of Blood Plasma Fractionation, Date of Enter into This Industry
3.9 Global Blood Plasma Fractionation Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Takeda
4.1.1 Takeda Company Information
4.1.2 Takeda Business Overview
4.1.3 Takeda Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
4.1.4 Takeda Blood Plasma Fractionation Product Portfolio
4.1.5 Takeda Recent Developments
4.2 CSL
4.2.1 CSL Company Information
4.2.2 CSL Business Overview
4.2.3 CSL Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
4.2.4 CSL Blood Plasma Fractionation Product Portfolio
4.2.5 CSL Recent Developments
4.3 Grifols
4.3.1 Grifols Company Information
4.3.2 Grifols Business Overview
4.3.3 Grifols Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
4.3.4 Grifols Blood Plasma Fractionation Product Portfolio
4.3.5 Grifols Recent Developments
4.4 Octapharma
4.4.1 Octapharma Company Information
4.4.2 Octapharma Business Overview
4.4.3 Octapharma Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
4.4.4 Octapharma Blood Plasma Fractionation Product Portfolio
4.4.5 Octapharma Recent Developments
4.5 Kedrion
4.5.1 Kedrion Company Information
4.5.2 Kedrion Business Overview
4.5.3 Kedrion Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Kedrion Blood Plasma Fractionation Product Portfolio
6.5.5 Kedrion Recent Developments
4.6 LFB Group
4.6.1 LFB Group Company Information
4.6.2 LFB Group Business Overview
4.6.3 LFB Group Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
4.6.4 LFB Group Blood Plasma Fractionation Product Portfolio
4.6.5 LFB Group Recent Developments
4.7 Biotest
4.7.1 Biotest Company Information
4.7.2 Biotest Business Overview
4.7.3 Biotest Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
4.7.4 Biotest Blood Plasma Fractionation Product Portfolio
4.7.5 Biotest Recent Developments
6.8 BPL
4.8.1 BPL Company Information
4.8.2 BPL Business Overview
4.8.3 BPL Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
4.8.4 BPL Blood Plasma Fractionation Product Portfolio
4.8.5 BPL Recent Developments
4.9 RAAS
4.9.1 RAAS Company Information
4.9.2 RAAS Business Overview
4.9.3 RAAS Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
4.9.4 RAAS Blood Plasma Fractionation Product Portfolio
4.9.5 RAAS Recent Developments
4.10 CBPO
4.10.1 CBPO Company Information
4.10.2 CBPO Business Overview
4.10.3 CBPO Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
4.10.4 CBPO Blood Plasma Fractionation Product Portfolio
4.10.5 CBPO Recent Developments
6.11 Hualan Bio
6.11.1 Hualan Bio Company Information
6.11.2 Hualan Bio Blood Plasma Fractionation Business Overview
6.11.3 Hualan Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Hualan Bio Blood Plasma Fractionation Product Portfolio
6.11.5 Hualan Bio Recent Developments
6.12 Tiantan Bio
6.12.1 Tiantan Bio Company Information
6.12.2 Tiantan Bio Blood Plasma Fractionation Business Overview
6.12.3 Tiantan Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Tiantan Bio Blood Plasma Fractionation Product Portfolio
6.12.5 Tiantan Bio Recent Developments
6.13 Shuanglin Bio
6.13.1 Shuanglin Bio Company Information
6.13.2 Shuanglin Bio Blood Plasma Fractionation Business Overview
6.13.3 Shuanglin Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Shuanglin Bio Blood Plasma Fractionation Product Portfolio
6.13.5 Shuanglin Bio Recent Developments
6.14 Boya Bio
6.14.1 Boya Bio Company Information
6.14.2 Boya Bio Blood Plasma Fractionation Business Overview
6.14.3 Boya Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Boya Bio Blood Plasma Fractionation Product Portfolio
6.14.5 Boya Bio Recent Developments
6.15 Yuanda Shuyang
6.15.1 Yuanda Shuyang Company Information
6.15.2 Yuanda Shuyang Blood Plasma Fractionation Business Overview
6.15.3 Yuanda Shuyang Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Yuanda Shuyang Blood Plasma Fractionation Product Portfolio
6.15.5 Yuanda Shuyang Recent Developments
6.16 Weiguang Bio
6.16.1 Weiguang Bio Company Information
6.16.2 Weiguang Bio Blood Plasma Fractionation Business Overview
6.16.3 Weiguang Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Weiguang Bio Blood Plasma Fractionation Product Portfolio
6.16.5 Weiguang Bio Recent Developments
6.17 Nanyue Bio
6.17.1 Nanyue Bio Company Information
6.17.2 Nanyue Bio Blood Plasma Fractionation Business Overview
6.17.3 Nanyue Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Nanyue Bio Blood Plasma Fractionation Product Portfolio
6.17.5 Nanyue Bio Recent Developments
6.18 KM Biologics
6.18.1 KM Biologics Company Information
6.18.2 KM Biologics Blood Plasma Fractionation Business Overview
6.18.3 KM Biologics Blood Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
6.18.4 KM Biologics Blood Plasma Fractionation Product Portfolio
6.18.5 KM Biologics Recent Developments
5 GLOBAL BLOOD PLASMA FRACTIONATION MARKET SCENARIO BY REGION
5.1 Global Blood Plasma Fractionation Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Blood Plasma Fractionation Sales by Region: 2018-2029
5.2.1 Global Blood Plasma Fractionation Sales by Region: 2018-2023
5.2.2 Global Blood Plasma Fractionation Sales by Region: 2024-2029
5.3 Global Blood Plasma Fractionation Revenue by Region: 2018-2029
5.3.1 Global Blood Plasma Fractionation Revenue by Region: 2018-2023
5.3.2 Global Blood Plasma Fractionation Revenue by Region: 2024-2029
5.4 North America Blood Plasma Fractionation Market Facts & Figures by Country
5.4.1 North America Blood Plasma Fractionation Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America Blood Plasma Fractionation Sales by Country (2018-2029)
5.4.3 North America Blood Plasma Fractionation Revenue by Country (2018-2029)
5.4.4 United States
5.4.5 Canada
5.5 Europe Blood Plasma Fractionation Market Facts & Figures by Country
5.5.1 Europe Blood Plasma Fractionation Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe Blood Plasma Fractionation Sales by Country (2018-2029)
5.5.3 Europe Blood Plasma Fractionation Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Blood Plasma Fractionation Market Facts & Figures by Country
5.6.1 Asia Pacific Blood Plasma Fractionation Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific Blood Plasma Fractionation Sales by Country (2018-2029)
5.6.3 Asia Pacific Blood Plasma Fractionation Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Blood Plasma Fractionation Market Facts & Figures by Country
5.7.1 Latin America Blood Plasma Fractionation Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America Blood Plasma Fractionation Sales by Country (2018-2029)
5.7.3 Latin America Blood Plasma Fractionation Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Blood Plasma Fractionation Market Facts & Figures by Country
5.8.1 Middle East and Africa Blood Plasma Fractionation Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa Blood Plasma Fractionation Sales by Country (2018-2029)
5.8.3 Middle East and Africa Blood Plasma Fractionation Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Blood Plasma Fractionation Sales by Type (2018-2029)
6.1.1 Global Blood Plasma Fractionation Sales by Type (2018-2029) & (K Units)
6.1.2 Global Blood Plasma Fractionation Sales Market Share by Type (2018-2029)
6.2 Global Blood Plasma Fractionation Revenue by Type (2018-2029)
6.2.1 Global Blood Plasma Fractionation Sales by Type (2018-2029) & (US$ Million)
6.2.2 Global Blood Plasma Fractionation Revenue Market Share by Type (2018-2029)
6.3 Global Blood Plasma Fractionation Price by Type (2018-2029)
7 SEGMENT BY APPLICATION
7.1 Global Blood Plasma Fractionation Sales by Application (2018-2029)
7.1.1 Global Blood Plasma Fractionation Sales by Application (2018-2029) & (K Units)
7.1.2 Global Blood Plasma Fractionation Sales Market Share by Application (2018-2029)
7.2 Global Blood Plasma Fractionation Revenue by Application (2018-2029)
6.2.1 Global Blood Plasma Fractionation Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global Blood Plasma Fractionation Revenue Market Share by Application (2018-2029)
7.3 Global Blood Plasma Fractionation Price by Application (2018-2029)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Blood Plasma Fractionation Value Chain Analysis
8.1.1 Blood Plasma Fractionation Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Blood Plasma Fractionation Production Mode & Process
8.2 Blood Plasma Fractionation Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Blood Plasma Fractionation Distributors
8.2.3 Blood Plasma Fractionation Customers
9 GLOBAL BLOOD PLASMA FRACTIONATION ANALYZING MARKET DYNAMICS
9.1 Blood Plasma Fractionation Industry Trends
9.2 Blood Plasma Fractionation Industry Drivers
9.3 Blood Plasma Fractionation Industry Opportunities and Challenges
9.4 Blood Plasma Fractionation Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Blood Plasma Fractionation Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Blood Plasma Fractionation Sales (K Units) of Manufacturers (2018-2023)
Table 7. Global Blood Plasma Fractionation Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Blood Plasma Fractionation Revenue of Manufacturers (2018-2023)
Table 9. Global Blood Plasma Fractionation Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Blood Plasma Fractionation Average Price (US$/Unit) of Manufacturers (2018-2023)
Table 11. Global Blood Plasma Fractionation Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Blood Plasma Fractionation, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Blood Plasma Fractionation by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Takeda Company Information
Table 17. Takeda Business Overview
Table 18. Takeda Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 19. Takeda Blood Plasma Fractionation Product Portfolio
Table 20. Takeda Recent Developments
Table 21. CSL Company Information
Table 22. CSL Business Overview
Table 23. CSL Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 24. CSL Blood Plasma Fractionation Product Portfolio
Table 25. CSL Recent Developments
Table 26. Grifols Company Information
Table 27. Grifols Business Overview
Table 28. Grifols Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 29. Grifols Blood Plasma Fractionation Product Portfolio
Table 30. Grifols Recent Developments
Table 31. Octapharma Company Information
Table 32. Octapharma Business Overview
Table 33. Octapharma Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 34. Octapharma Blood Plasma Fractionation Product Portfolio
Table 35. Octapharma Recent Developments
Table 36. Kedrion Company Information
Table 37. Kedrion Business Overview
Table 38. Kedrion Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 39. Kedrion Blood Plasma Fractionation Product Portfolio
Table 40. Kedrion Recent Developments
Table 41. LFB Group Company Information
Table 42. LFB Group Business Overview
Table 43. LFB Group Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 44. LFB Group Blood Plasma Fractionation Product Portfolio
Table 45. LFB Group Recent Developments
Table 46. Biotest Company Information
Table 47. Biotest Business Overview
Table 48. Biotest Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 49. Biotest Blood Plasma Fractionation Product Portfolio
Table 50. Biotest Recent Developments
Table 51. BPL Company Information
Table 52. BPL Business Overview
Table 53. BPL Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 54. BPL Blood Plasma Fractionation Product Portfolio
Table 55. BPL Recent Developments
Table 56. RAAS Company Information
Table 57. RAAS Business Overview
Table 58. RAAS Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 59. RAAS Blood Plasma Fractionation Product Portfolio
Table 60. RAAS Recent Developments
Table 61. CBPO Company Information
Table 62. CBPO Business Overview
Table 63. CBPO Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 64. CBPO Blood Plasma Fractionation Product Portfolio
Table 65. CBPO Recent Developments
Table 66. Hualan Bio Company Information
Table 67. Hualan Bio Business Overview
Table 68. Hualan Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 69. Hualan Bio Blood Plasma Fractionation Product Portfolio
Table 70. Hualan Bio Recent Developments
Table 71. Tiantan Bio Company Information
Table 72. Tiantan Bio Business Overview
Table 73. Tiantan Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 74. Tiantan Bio Blood Plasma Fractionation Product Portfolio
Table 75. Tiantan Bio Recent Developments
Table 76. Shuanglin Bio Company Information
Table 77. Shuanglin Bio Business Overview
Table 78. Shuanglin Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 79. Shuanglin Bio Blood Plasma Fractionation Product Portfolio
Table 80. Shuanglin Bio Recent Developments
Table 81. Boya Bio Company Information
Table 82. Boya Bio Business Overview
Table 83. Boya Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. Boya Bio Blood Plasma Fractionation Product Portfolio
Table 85. Boya Bio Recent Developments
Table 86. Yuanda Shuyang Company Information
Table 87. Yuanda Shuyang Business Overview
Table 88. Yuanda Shuyang Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. Yuanda Shuyang Blood Plasma Fractionation Product Portfolio
Table 90. Yuanda Shuyang Recent Developments
Table 91. Weiguang Bio Company Information
Table 92. Weiguang Bio Business Overview
Table 93. Weiguang Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Weiguang Bio Blood Plasma Fractionation Product Portfolio
Table 95. Weiguang Bio Recent Developments
Table 96. Nanyue Bio Company Information
Table 97. Nanyue Bio Business Overview
Table 98. Nanyue Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. Nanyue Bio Blood Plasma Fractionation Product Portfolio
Table 100. Nanyue Bio Recent Developments
Table 101. KM Biologics Company Information
Table 102. KM Biologics Business Overview
Table 103. KM Biologics Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. KM Biologics Blood Plasma Fractionation Product Portfolio
Table 105. KM Biologics Recent Developments
Table 106. Global Blood Plasma Fractionation Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 107. Global Blood Plasma Fractionation Sales by Region (2018-2023) & (K Units)
Table 108. Global Blood Plasma Fractionation Sales Market Share by Region (2018-2023)
Table 109. Global Blood Plasma Fractionation Sales by Region (2024-2029) & (K Units)
Table 110. Global Blood Plasma Fractionation Sales Market Share by Region (2024-2029)
Table 111. Global Blood Plasma Fractionation Revenue by Region (2018-2023) & (US$ Million)
Table 112. Global Blood Plasma Fractionation Revenue Market Share by Region (2018-2023)
Table 113. Global Blood Plasma Fractionation Revenue by Region (2024-2029) & (US$ Million)
Table 114. Global Blood Plasma Fractionation Revenue Market Share by Region (2024-2029)
Table 115. North America Blood Plasma Fractionation Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 116. North America Blood Plasma Fractionation Sales by Country (2018-2023) & (K Units)
Table 117. North America Blood Plasma Fractionation Sales by Country (2024-2029) & (K Units)
Table 118. North America Blood Plasma Fractionation Revenue by Country (2018-2023) & (US$ Million)
Table 119. North America Blood Plasma Fractionation Revenue by Country (2024-2029) & (US$ Million)
Table 120. Europe Blood Plasma Fractionation Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 121. Europe Blood Plasma Fractionation Sales by Country (2018-2023) & (K Units)
Table 122. Europe Blood Plasma Fractionation Sales by Country (2024-2029) & (K Units)
Table 123. Europe Blood Plasma Fractionation Revenue by Country (2018-2023) & (US$ Million)
Table 124. Europe Blood Plasma Fractionation Revenue by Country (2024-2029) & (US$ Million)
Table 125. Asia Pacific Blood Plasma Fractionation Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 126. Asia Pacific Blood Plasma Fractionation Sales by Country (2018-2023) & (K Units)
Table 127. Asia Pacific Blood Plasma Fractionation Sales by Country (2024-2029) & (K Units)
Table 128. Asia Pacific Blood Plasma Fractionation Revenue by Country (2018-2023) & (US$ Million)
Table 129. Asia Pacific Blood Plasma Fractionation Revenue by Country (2024-2029) & (US$ Million)
Table 130. Latin America Blood Plasma Fractionation Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 131. Latin America Blood Plasma Fractionation Sales by Country (2018-2023) & (K Units)
Table 132. Latin America Blood Plasma Fractionation Sales by Country (2024-2029) & (K Units)
Table 133. Latin America Blood Plasma Fractionation Revenue by Country (2018-2023) & (US$ Million)
Table 134. Latin America Blood Plasma Fractionation Revenue by Country (2024-2029) & (US$ Million)
Table 135. Middle East and Africa Blood Plasma Fractionation Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 136. Middle East and Africa Blood Plasma Fractionation Sales by Country (2018-2023) & (K Units)
Table 137. Middle East and Africa Blood Plasma Fractionation Sales by Country (2024-2029) & (K Units)
Table 138. Middle East and Africa Blood Plasma Fractionation Revenue by Country (2018-2023) & (US$ Million)
Table 139. Middle East and Africa Blood Plasma Fractionation Revenue by Country (2024-2029) & (US$ Million)
Table 140. Global Blood Plasma Fractionation Sales by Type (2018-2023) & (K Units)
Table 141. Global Blood Plasma Fractionation Sales by Type (2024-2029) & (K Units)
Table 142. Global Blood Plasma Fractionation Sales Market Share by Type (2018-2023)
Table 143. Global Blood Plasma Fractionation Sales Market Share by Type (2024-2029)
Table 144. Global Blood Plasma Fractionation Revenue by Type (2018-2023) & (US$ Million)
Table 145. Global Blood Plasma Fractionation Revenue by Type (2024-2029) & (US$ Million)
Table 146. Global Blood Plasma Fractionation Revenue Market Share by Type (2018-2023)
Table 147. Global Blood Plasma Fractionation Revenue Market Share by Type (2024-2029)
Table 148. Global Blood Plasma Fractionation Price by Type (2018-2023) & (US$/Unit)
Table 149. Global Blood Plasma Fractionation Price by Type (2024-2029) & (US$/Unit)
Table 150. Global Blood Plasma Fractionation Sales by Application (2018-2023) & (K Units)
Table 151. Global Blood Plasma Fractionation Sales by Application (2024-2029) & (K Units)
Table 152. Global Blood Plasma Fractionation Sales Market Share by Application (2018-2023)
Table 153. Global Blood Plasma Fractionation Sales Market Share by Application (2024-2029)
Table 154. Global Blood Plasma Fractionation Revenue by Application (2018-2023) & (US$ Million)
Table 155. Global Blood Plasma Fractionation Revenue by Application (2024-2029) & (US$ Million)
Table 156. Global Blood Plasma Fractionation Revenue Market Share by Application (2018-2023)
Table 157. Global Blood Plasma Fractionation Revenue Market Share by Application (2024-2029)
Table 158. Global Blood Plasma Fractionation Price by Application (2018-2023) & (US$/Unit)
Table 159. Global Blood Plasma Fractionation Price by Application (2024-2029) & (US$/Unit)
Table 160. Key Raw Materials
Table 161. Raw Materials Key Suppliers
Table 162. Blood Plasma Fractionation Distributors List
Table 163. Blood Plasma Fractionation Customers List
Table 164. Blood Plasma Fractionation Industry Trends
Table 165. Blood Plasma Fractionation Industry Drivers
Table 166. Blood Plasma Fractionation Industry Restraints
Table 167. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Blood Plasma Fractionation Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Blood Plasma Fractionation Sales (K Units) of Manufacturers (2018-2023)
Table 7. Global Blood Plasma Fractionation Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Blood Plasma Fractionation Revenue of Manufacturers (2018-2023)
Table 9. Global Blood Plasma Fractionation Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Blood Plasma Fractionation Average Price (US$/Unit) of Manufacturers (2018-2023)
Table 11. Global Blood Plasma Fractionation Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Blood Plasma Fractionation, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Blood Plasma Fractionation by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Takeda Company Information
Table 17. Takeda Business Overview
Table 18. Takeda Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 19. Takeda Blood Plasma Fractionation Product Portfolio
Table 20. Takeda Recent Developments
Table 21. CSL Company Information
Table 22. CSL Business Overview
Table 23. CSL Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 24. CSL Blood Plasma Fractionation Product Portfolio
Table 25. CSL Recent Developments
Table 26. Grifols Company Information
Table 27. Grifols Business Overview
Table 28. Grifols Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 29. Grifols Blood Plasma Fractionation Product Portfolio
Table 30. Grifols Recent Developments
Table 31. Octapharma Company Information
Table 32. Octapharma Business Overview
Table 33. Octapharma Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 34. Octapharma Blood Plasma Fractionation Product Portfolio
Table 35. Octapharma Recent Developments
Table 36. Kedrion Company Information
Table 37. Kedrion Business Overview
Table 38. Kedrion Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 39. Kedrion Blood Plasma Fractionation Product Portfolio
Table 40. Kedrion Recent Developments
Table 41. LFB Group Company Information
Table 42. LFB Group Business Overview
Table 43. LFB Group Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 44. LFB Group Blood Plasma Fractionation Product Portfolio
Table 45. LFB Group Recent Developments
Table 46. Biotest Company Information
Table 47. Biotest Business Overview
Table 48. Biotest Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 49. Biotest Blood Plasma Fractionation Product Portfolio
Table 50. Biotest Recent Developments
Table 51. BPL Company Information
Table 52. BPL Business Overview
Table 53. BPL Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 54. BPL Blood Plasma Fractionation Product Portfolio
Table 55. BPL Recent Developments
Table 56. RAAS Company Information
Table 57. RAAS Business Overview
Table 58. RAAS Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 59. RAAS Blood Plasma Fractionation Product Portfolio
Table 60. RAAS Recent Developments
Table 61. CBPO Company Information
Table 62. CBPO Business Overview
Table 63. CBPO Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 64. CBPO Blood Plasma Fractionation Product Portfolio
Table 65. CBPO Recent Developments
Table 66. Hualan Bio Company Information
Table 67. Hualan Bio Business Overview
Table 68. Hualan Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 69. Hualan Bio Blood Plasma Fractionation Product Portfolio
Table 70. Hualan Bio Recent Developments
Table 71. Tiantan Bio Company Information
Table 72. Tiantan Bio Business Overview
Table 73. Tiantan Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 74. Tiantan Bio Blood Plasma Fractionation Product Portfolio
Table 75. Tiantan Bio Recent Developments
Table 76. Shuanglin Bio Company Information
Table 77. Shuanglin Bio Business Overview
Table 78. Shuanglin Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 79. Shuanglin Bio Blood Plasma Fractionation Product Portfolio
Table 80. Shuanglin Bio Recent Developments
Table 81. Boya Bio Company Information
Table 82. Boya Bio Business Overview
Table 83. Boya Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. Boya Bio Blood Plasma Fractionation Product Portfolio
Table 85. Boya Bio Recent Developments
Table 86. Yuanda Shuyang Company Information
Table 87. Yuanda Shuyang Business Overview
Table 88. Yuanda Shuyang Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. Yuanda Shuyang Blood Plasma Fractionation Product Portfolio
Table 90. Yuanda Shuyang Recent Developments
Table 91. Weiguang Bio Company Information
Table 92. Weiguang Bio Business Overview
Table 93. Weiguang Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Weiguang Bio Blood Plasma Fractionation Product Portfolio
Table 95. Weiguang Bio Recent Developments
Table 96. Nanyue Bio Company Information
Table 97. Nanyue Bio Business Overview
Table 98. Nanyue Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. Nanyue Bio Blood Plasma Fractionation Product Portfolio
Table 100. Nanyue Bio Recent Developments
Table 101. KM Biologics Company Information
Table 102. KM Biologics Business Overview
Table 103. KM Biologics Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. KM Biologics Blood Plasma Fractionation Product Portfolio
Table 105. KM Biologics Recent Developments
Table 106. Global Blood Plasma Fractionation Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 107. Global Blood Plasma Fractionation Sales by Region (2018-2023) & (K Units)
Table 108. Global Blood Plasma Fractionation Sales Market Share by Region (2018-2023)
Table 109. Global Blood Plasma Fractionation Sales by Region (2024-2029) & (K Units)
Table 110. Global Blood Plasma Fractionation Sales Market Share by Region (2024-2029)
Table 111. Global Blood Plasma Fractionation Revenue by Region (2018-2023) & (US$ Million)
Table 112. Global Blood Plasma Fractionation Revenue Market Share by Region (2018-2023)
Table 113. Global Blood Plasma Fractionation Revenue by Region (2024-2029) & (US$ Million)
Table 114. Global Blood Plasma Fractionation Revenue Market Share by Region (2024-2029)
Table 115. North America Blood Plasma Fractionation Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 116. North America Blood Plasma Fractionation Sales by Country (2018-2023) & (K Units)
Table 117. North America Blood Plasma Fractionation Sales by Country (2024-2029) & (K Units)
Table 118. North America Blood Plasma Fractionation Revenue by Country (2018-2023) & (US$ Million)
Table 119. North America Blood Plasma Fractionation Revenue by Country (2024-2029) & (US$ Million)
Table 120. Europe Blood Plasma Fractionation Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 121. Europe Blood Plasma Fractionation Sales by Country (2018-2023) & (K Units)
Table 122. Europe Blood Plasma Fractionation Sales by Country (2024-2029) & (K Units)
Table 123. Europe Blood Plasma Fractionation Revenue by Country (2018-2023) & (US$ Million)
Table 124. Europe Blood Plasma Fractionation Revenue by Country (2024-2029) & (US$ Million)
Table 125. Asia Pacific Blood Plasma Fractionation Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 126. Asia Pacific Blood Plasma Fractionation Sales by Country (2018-2023) & (K Units)
Table 127. Asia Pacific Blood Plasma Fractionation Sales by Country (2024-2029) & (K Units)
Table 128. Asia Pacific Blood Plasma Fractionation Revenue by Country (2018-2023) & (US$ Million)
Table 129. Asia Pacific Blood Plasma Fractionation Revenue by Country (2024-2029) & (US$ Million)
Table 130. Latin America Blood Plasma Fractionation Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 131. Latin America Blood Plasma Fractionation Sales by Country (2018-2023) & (K Units)
Table 132. Latin America Blood Plasma Fractionation Sales by Country (2024-2029) & (K Units)
Table 133. Latin America Blood Plasma Fractionation Revenue by Country (2018-2023) & (US$ Million)
Table 134. Latin America Blood Plasma Fractionation Revenue by Country (2024-2029) & (US$ Million)
Table 135. Middle East and Africa Blood Plasma Fractionation Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 136. Middle East and Africa Blood Plasma Fractionation Sales by Country (2018-2023) & (K Units)
Table 137. Middle East and Africa Blood Plasma Fractionation Sales by Country (2024-2029) & (K Units)
Table 138. Middle East and Africa Blood Plasma Fractionation Revenue by Country (2018-2023) & (US$ Million)
Table 139. Middle East and Africa Blood Plasma Fractionation Revenue by Country (2024-2029) & (US$ Million)
Table 140. Global Blood Plasma Fractionation Sales by Type (2018-2023) & (K Units)
Table 141. Global Blood Plasma Fractionation Sales by Type (2024-2029) & (K Units)
Table 142. Global Blood Plasma Fractionation Sales Market Share by Type (2018-2023)
Table 143. Global Blood Plasma Fractionation Sales Market Share by Type (2024-2029)
Table 144. Global Blood Plasma Fractionation Revenue by Type (2018-2023) & (US$ Million)
Table 145. Global Blood Plasma Fractionation Revenue by Type (2024-2029) & (US$ Million)
Table 146. Global Blood Plasma Fractionation Revenue Market Share by Type (2018-2023)
Table 147. Global Blood Plasma Fractionation Revenue Market Share by Type (2024-2029)
Table 148. Global Blood Plasma Fractionation Price by Type (2018-2023) & (US$/Unit)
Table 149. Global Blood Plasma Fractionation Price by Type (2024-2029) & (US$/Unit)
Table 150. Global Blood Plasma Fractionation Sales by Application (2018-2023) & (K Units)
Table 151. Global Blood Plasma Fractionation Sales by Application (2024-2029) & (K Units)
Table 152. Global Blood Plasma Fractionation Sales Market Share by Application (2018-2023)
Table 153. Global Blood Plasma Fractionation Sales Market Share by Application (2024-2029)
Table 154. Global Blood Plasma Fractionation Revenue by Application (2018-2023) & (US$ Million)
Table 155. Global Blood Plasma Fractionation Revenue by Application (2024-2029) & (US$ Million)
Table 156. Global Blood Plasma Fractionation Revenue Market Share by Application (2018-2023)
Table 157. Global Blood Plasma Fractionation Revenue Market Share by Application (2024-2029)
Table 158. Global Blood Plasma Fractionation Price by Application (2018-2023) & (US$/Unit)
Table 159. Global Blood Plasma Fractionation Price by Application (2024-2029) & (US$/Unit)
Table 160. Key Raw Materials
Table 161. Raw Materials Key Suppliers
Table 162. Blood Plasma Fractionation Distributors List
Table 163. Blood Plasma Fractionation Customers List
Table 164. Blood Plasma Fractionation Industry Trends
Table 165. Blood Plasma Fractionation Industry Drivers
Table 166. Blood Plasma Fractionation Industry Restraints
Table 167. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Blood Plasma FractionationProduct Picture
Figure 5. Global Blood Plasma Fractionation Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Blood Plasma Fractionation Market Size (2018-2029) & (US$ Million)
Figure 7. Global Blood Plasma Fractionation Sales (2018-2029) & (K Units)
Figure 8. Global Blood Plasma Fractionation Average Price (US$/Unit) & (2018-2029)
Figure 9. Immune Globulin Product Picture
Figure 10. Coagulation Factor Product Picture
Figure 11. Albumin Product Picture
Figure 12. Others Product Picture
Figure 13. Hospital Product Picture
Figure 14. Retail Pharmacy Product Picture
Figure 15. Others Product Picture
Figure 16. Global Blood Plasma Fractionation Revenue Share by Manufacturers in 2022
Figure 17. Global Manufacturers of Blood Plasma Fractionation, Manufacturing Sites & Headquarters
Figure 18. Global Manufacturers of Blood Plasma Fractionation, Date of Enter into This Industry
Figure 19. Global Top 5 and 10 Blood Plasma Fractionation Players Market Share by Revenue in 2022
Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 21. Global Blood Plasma Fractionation Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. Global Blood Plasma Fractionation Sales by Region in 2022
Figure 23. Global Blood Plasma Fractionation Revenue by Region in 2022
Figure 24. North America Blood Plasma Fractionation Market Size by Country in 2022
Figure 25. North America Blood Plasma Fractionation Sales Market Share by Country (2018-2029)
Figure 26. North America Blood Plasma Fractionation Revenue Market Share by Country (2018-2029)
Figure 27. United States Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Canada Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Europe Blood Plasma Fractionation Market Size by Country in 2022
Figure 30. Europe Blood Plasma Fractionation Sales Market Share by Country (2018-2029)
Figure 31. Europe Blood Plasma Fractionation Revenue Market Share by Country (2018-2029)
Figure 32. Germany Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. France Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. U.K. Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Italy Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Russia Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Asia Pacific Blood Plasma Fractionation Market Size by Country in 2022
Figure 38. Asia Pacific Blood Plasma Fractionation Sales Market Share by Country (2018-2029)
Figure 39. Asia Pacific Blood Plasma Fractionation Revenue Market Share by Country (2018-2029)
Figure 40. China Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Japan Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. South Korea Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. India Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Australia Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. China Taiwan Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Indonesia Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Thailand Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Malaysia Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Latin America Blood Plasma Fractionation Market Size by Country in 2022
Figure 50. Latin America Blood Plasma Fractionation Sales Market Share by Country (2018-2029)
Figure 51. Latin America Blood Plasma Fractionation Revenue Market Share by Country (2018-2029)
Figure 52. Mexico Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Brazil Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Argentina Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Middle East and Africa Blood Plasma Fractionation Market Size by Country in 2022
Figure 56. Middle East and Africa Blood Plasma Fractionation Sales Market Share by Country (2018-2029)
Figure 57. Middle East and Africa Blood Plasma Fractionation Revenue Market Share by Country (2018-2029)
Figure 58. Turkey Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Saudi Arabia Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 60. UAE Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 61. Global Blood Plasma Fractionation Sales Market Share by Type (2018-2029)
Figure 62. Global Blood Plasma Fractionation Revenue Market Share by Type (2018-2029)
Figure 63. Global Blood Plasma Fractionation Price (US$/Unit) by Type (2018-2029)
Figure 64. Global Blood Plasma Fractionation Sales Market Share by Application (2018-2029)
Figure 65. Global Blood Plasma Fractionation Revenue Market Share by Application (2018-2029)
Figure 66. Global Blood Plasma Fractionation Price (US$/Unit) by Application (2018-2029)
Figure 67. Blood Plasma Fractionation Value Chain
Figure 68. Blood Plasma Fractionation Production Mode & Process
Figure 69. Direct Comparison with Distribution Share
Figure 70. Distributors Profiles
Figure 71. Blood Plasma Fractionation Industry Opportunities and Challenges
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Blood Plasma FractionationProduct Picture
Figure 5. Global Blood Plasma Fractionation Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Blood Plasma Fractionation Market Size (2018-2029) & (US$ Million)
Figure 7. Global Blood Plasma Fractionation Sales (2018-2029) & (K Units)
Figure 8. Global Blood Plasma Fractionation Average Price (US$/Unit) & (2018-2029)
Figure 9. Immune Globulin Product Picture
Figure 10. Coagulation Factor Product Picture
Figure 11. Albumin Product Picture
Figure 12. Others Product Picture
Figure 13. Hospital Product Picture
Figure 14. Retail Pharmacy Product Picture
Figure 15. Others Product Picture
Figure 16. Global Blood Plasma Fractionation Revenue Share by Manufacturers in 2022
Figure 17. Global Manufacturers of Blood Plasma Fractionation, Manufacturing Sites & Headquarters
Figure 18. Global Manufacturers of Blood Plasma Fractionation, Date of Enter into This Industry
Figure 19. Global Top 5 and 10 Blood Plasma Fractionation Players Market Share by Revenue in 2022
Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 21. Global Blood Plasma Fractionation Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. Global Blood Plasma Fractionation Sales by Region in 2022
Figure 23. Global Blood Plasma Fractionation Revenue by Region in 2022
Figure 24. North America Blood Plasma Fractionation Market Size by Country in 2022
Figure 25. North America Blood Plasma Fractionation Sales Market Share by Country (2018-2029)
Figure 26. North America Blood Plasma Fractionation Revenue Market Share by Country (2018-2029)
Figure 27. United States Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Canada Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Europe Blood Plasma Fractionation Market Size by Country in 2022
Figure 30. Europe Blood Plasma Fractionation Sales Market Share by Country (2018-2029)
Figure 31. Europe Blood Plasma Fractionation Revenue Market Share by Country (2018-2029)
Figure 32. Germany Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. France Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. U.K. Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Italy Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Russia Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Asia Pacific Blood Plasma Fractionation Market Size by Country in 2022
Figure 38. Asia Pacific Blood Plasma Fractionation Sales Market Share by Country (2018-2029)
Figure 39. Asia Pacific Blood Plasma Fractionation Revenue Market Share by Country (2018-2029)
Figure 40. China Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Japan Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. South Korea Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. India Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Australia Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. China Taiwan Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Indonesia Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Thailand Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Malaysia Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Latin America Blood Plasma Fractionation Market Size by Country in 2022
Figure 50. Latin America Blood Plasma Fractionation Sales Market Share by Country (2018-2029)
Figure 51. Latin America Blood Plasma Fractionation Revenue Market Share by Country (2018-2029)
Figure 52. Mexico Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Brazil Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Argentina Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Middle East and Africa Blood Plasma Fractionation Market Size by Country in 2022
Figure 56. Middle East and Africa Blood Plasma Fractionation Sales Market Share by Country (2018-2029)
Figure 57. Middle East and Africa Blood Plasma Fractionation Revenue Market Share by Country (2018-2029)
Figure 58. Turkey Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Saudi Arabia Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 60. UAE Blood Plasma Fractionation Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 61. Global Blood Plasma Fractionation Sales Market Share by Type (2018-2029)
Figure 62. Global Blood Plasma Fractionation Revenue Market Share by Type (2018-2029)
Figure 63. Global Blood Plasma Fractionation Price (US$/Unit) by Type (2018-2029)
Figure 64. Global Blood Plasma Fractionation Sales Market Share by Application (2018-2029)
Figure 65. Global Blood Plasma Fractionation Revenue Market Share by Application (2018-2029)
Figure 66. Global Blood Plasma Fractionation Price (US$/Unit) by Application (2018-2029)
Figure 67. Blood Plasma Fractionation Value Chain
Figure 68. Blood Plasma Fractionation Production Mode & Process
Figure 69. Direct Comparison with Distribution Share
Figure 70. Distributors Profiles
Figure 71. Blood Plasma Fractionation Industry Opportunities and Challenges
